2021
Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS
Shin J, Geetha D, Szpirt W, Windpessl M, Kronbichler A. Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS. Therapeutic Apheresis And Dialysis 2021, 26: 24-31. PMID: 34339589, DOI: 10.1111/1744-9987.13718.Peer-Reviewed Original ResearchConceptsAnti-GBM diseasePlasma exchangePoor prognosisCombination of therapeutic plasma exchangeGoodpasture's diseaseAnti-glomerular basement membrane diseaseAnti-glomerular basement membraneANCA-associated vasculitisPhase II trialStandard of care managementTherapeutic plasma exchangeBasement membrane diseaseLong-term treatmentAnti-GBM antibodiesSevere kidney failureSevere disease phenotypePrognostic factorsII trialMembrane diseasePulmonary hemorrhageEarly initiationRefine treatment approachesKidney failureTreatment approachesPatients
2013
The role of Interleukin-23/Interleukin-17 axis in coexisting anti-glomerular basement membrane disease and lupus nephritis
Park J, Kim J, Ha T, Shin J. The role of Interleukin-23/Interleukin-17 axis in coexisting anti-glomerular basement membrane disease and lupus nephritis. Saudi Journal Of Kidney Diseases And Transplantation 2013, 24: 596-597. PMID: 23640643, DOI: 10.4103/1319-2442.111079.Peer-Reviewed Original Research
2011
The Influence of Age on the Clinical Features and Outcomes of Anti–Glomerular Basement Membrane Disease
Park J, Kim J, Shin J. The Influence of Age on the Clinical Features and Outcomes of Anti–Glomerular Basement Membrane Disease. American Journal Of Kidney Diseases 2011, 58: 678. PMID: 21944964, DOI: 10.1053/j.ajkd.2011.07.009.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply